ETM
LH icon

Euclidean Technologies Management’s Labcorp LH Stock Holding History

Euclidean Technologies Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-988
Closed -$224K – 79
2022
Q1 		$224K Hold
988
– – 0.21% 68
2021
Q4 		$267K Hold
988
– – 0.22% 60
2021
Q3 		$239K Hold
988
– – 0.21% 60
2021
Q2 		$234K Buy
+988
New +$225K 0.19% 67

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Euclidean Technologies Management's LH Position: Q2 2022 in Review

Euclidean Technologies Management sold out of Labcorp (LH) in Q2 2022, closing a stake of 988 shares — an estimated $224K sold.

Euclidean Technologies Management first reported a position in LH in Q2 2021 and held it in 4 quarters. The position peaked at $267K in Q4 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Euclidean Technologies Management reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • Euclidean Technologies Management sold 988 Labcorp shares in Q2 2022, an estimated $224K.
  • Euclidean Technologies Management first reported a position in Labcorp in Q2 2021 and held it in 4 quarters.
  • Euclidean Technologies Management's Labcorp position peaked at $267K in Q4 2021.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Euclidean Technologies Management's 13F filing for Q2 2022, filed 25 Jul 2022.